65例小细胞肺癌化疗与化疗后放疗对比

• 作 者: 许殿元 席承恩 张新华 郭彤军 梁翠珍
• 机 构: 解放军二六四医院临床实验科,解放军二六四医院临床实验科,解放军二六四医院临床实验科,解放军二六四医院临床实验科,解放军二六四医院临床实验科 山西太原 030001,山西太原 030001,山西太原 0
• 出 处: 癌症
• 发表日期: 1991年06期
• 关键词: 肺癌化疗 淋巴结活检 中心型 经纤支镜 联合化疗 局限期 分组治疗 化疗有效率 扩散转移 药物化疗

小细胞肺癌(SCLC)占肺癌20～25％,是肺癌中易于早期扩散转移,预后较差的一个类型,随着近年来研究的进展和新药应用,SCLC疗效有了进一步提高。从1984年1月至1990年1月,共收治SCLC65例,现将分组治疗结果报告如下: 资料和方法 一、一般资料: 经纤支镜和淋巴结活检病理证实的SCLC65例,男51例,女14例;年龄24～70岁,平均54.6岁;中心型46例(70.76％),周围型19例(29.24％);按照

Small cell lung cancer (SCLC) accounts for 20 to 25% of lung cancer, which is a type of lung cancer that is easy to spread early and has a poor prognosis. With the development of research and application of new drugs in recent years, the efficacy of SCLC has been further improved. From January 1984 to January 1990, a total of 65 cases of SCLC were treated. The results of the group treatment are reported as follows: Materials and Methods I. General Information: 65 cases of SCLC confirmed by pathobronchoscopy and lymph node biopsy, male 51 cases, female 14 cases; aged 24-70 years, mean 54.6 years; 46 cases (70.76%) of central type, 19 cases (29.24%) of peripheral type;